These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3053183

  • 21. Cellular pathophysiology and therapy of pulmonary hypertension.
    Olschewski H, Rose F, Grünig E, Ghofrani HA, Walmrath D, Schulz R, Schermuly R, Grimminger F, Seeger W.
    J Lab Clin Med; 2001 Dec; 138(6):367-77. PubMed ID: 11753283
    [Abstract] [Full Text] [Related]

  • 22. Vasodilatory treatment of pulmonary hypertension.
    Widimský J.
    Eur J Respir Dis; 1986 Mar; 68(3):161-6. PubMed ID: 2870937
    [Abstract] [Full Text] [Related]

  • 23. The management of primary pulmonary hypertension.
    Palevsky HI, Fishman AP.
    JAMA; 1991 Feb 27; 265(8):1014-20. PubMed ID: 1992195
    [Abstract] [Full Text] [Related]

  • 24. [Heart pathology of extracardiac origin. IV. Pulmonary hypertension in chronic respiratory diseases].
    Barberà JA.
    Rev Esp Cardiol; 1998 Jan 27; 51(1):56-68. PubMed ID: 9522610
    [Abstract] [Full Text] [Related]

  • 25. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr 27; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 26. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S, Samoyeau R, Weitzenblum E.
    Blood Press Suppl; 1995 Apr 27; 3():47-57. PubMed ID: 8535542
    [Abstract] [Full Text] [Related]

  • 27. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N, Seybert A, Mathier MA.
    Clin Ther; 2007 Oct 27; 29(10):2134-53. PubMed ID: 18042471
    [Abstract] [Full Text] [Related]

  • 28. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA, Wang A, Harrison JK, Tapson VF, Bashore TM.
    Am Heart J; 2005 Oct 27; 150(4):725-8. PubMed ID: 16209974
    [Abstract] [Full Text] [Related]

  • 29. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension.
    Scott JP, Higenbottam T, Wallwork J.
    Br J Clin Pract; 1990 Jun 27; 44(6):231-4. PubMed ID: 1698429
    [Abstract] [Full Text] [Related]

  • 30. Modulating the pulmonary circulation: an update.
    Dembinski R, Henzler D, Rossaint R.
    Minerva Anestesiol; 2004 Apr 27; 70(4):239-43. PubMed ID: 15173703
    [Abstract] [Full Text] [Related]

  • 31. Pulmonary Vasodilators and Anesthesia Considerations.
    Green JB, Hart B, Cornett EM, Kaye AD, Salehi A, Fox CJ.
    Anesthesiol Clin; 2017 Jun 27; 35(2):221-232. PubMed ID: 28526144
    [Abstract] [Full Text] [Related]

  • 32. The case for treatment of selected patients with primary pulmonary hypertension.
    Reeves JT, Groves BM, Turkevich D.
    Am Rev Respir Dis; 1986 Aug 27; 134(2):342-6. PubMed ID: 3740659
    [Abstract] [Full Text] [Related]

  • 33. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI, Shettigar UR, Siddique M, Barbier G, Bialow M, Carranza S.
    Int J Clin Pharmacol Ther; 1998 Aug 27; 36(8):435-40. PubMed ID: 9726697
    [Abstract] [Full Text] [Related]

  • 34. Riociguat (Adempas). Chronic thromboembolic pulmonary hypertension with markedly restricted physical activity.
    Prescrire Int; 2015 Nov 27; 24(165):265-6. PubMed ID: 26688897
    [Abstract] [Full Text] [Related]

  • 35. The treatment of chronic pulmonary hypertension by vasodilators: hope and hesitation.
    Jezek V.
    Eur Heart J; 1988 Sep 27; 9 Suppl J():1-6. PubMed ID: 3053178
    [Abstract] [Full Text] [Related]

  • 36. Pulmonary hypertensive diseases.
    Rounds S, Hill NS.
    Chest; 1984 Mar 27; 85(3):397-405. PubMed ID: 6365477
    [Abstract] [Full Text] [Related]

  • 37. [Pulmonary arterial hypertension: medical treatment and surgical indications].
    Chabot F, Dinh-Xuan AT.
    Presse Med; 1995 Nov 04; 24(33):1574-6. PubMed ID: 8539219
    [Abstract] [Full Text] [Related]

  • 38. [Pulmonary hypertension due to left heart disease - not to be confused with pulmonary arterial hypertension].
    Lundgren J, Rådegran G.
    Lakartidningen; 2019 Mar 26; 116():. PubMed ID: 31192396
    [Abstract] [Full Text] [Related]

  • 39. [Prostanoids in the treatment of pulmonary arterial hypertension].
    Başkurt M, Küçükoğlu MS.
    Anadolu Kardiyol Derg; 2010 Sep 26; 10 Suppl 2():2-8. PubMed ID: 20819749
    [Abstract] [Full Text] [Related]

  • 40. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
    Tonelli AR, Alnuaimat H, Mubarak K.
    Respir Med; 2010 Apr 26; 104(4):481-96. PubMed ID: 20004088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.